A New Molecular Mechanism Underlying the Antitumor Effect of DNA Methylation Inhibitors via an Antiviral Immune Response

Advances in Protein Chemistry and Structural Biology

Volumn 106, Issue , 2017, Pages 227-242

  Saito, Y ^a   Nakaoka, T ^a   Saito, H ^a  

^a KEIO UNIVERSITY   (Japan)

Author keywords

Antiviral immune response; DNA methylation; Endogenous retrovirus; Histone modification; Interferon responsive gene

Indexed keywords

DOUBLE STRANDED RNA; MICRORNA; ANTINEOPLASTIC AGENT;

ANTINEOPLASTIC ACTIVITY; CANCER CELL; CELL PROLIFERATION; CHROMATIN ASSEMBLY AND DISASSEMBLY; DEMETHYLATION; DNA METHYLATION; ENDOGENOUS RETROVIRUS; HISTONE MODIFICATION; HUMAN; IMMUNE RESPONSE; NONHUMAN; STEM CELL; DRUG EFFECTS; IMMUNE SYSTEM;

ANTINEOPLASTIC AGENTS; DNA METHYLATION; HUMANS; IMMUNE SYSTEM;

EID: 84995757498     PISSN: 18761623     EISSN: None     Source Type: Book Series    
DOI: 10.1016/bs.apcsb.2016.08.005     Document Type: Chapter

References (51)

1. Bannert, N., Kurth, R., Retroelements and the human genome: New perspectives on an old relation. Proceedings of the National Academy of Sciences of the United States of America 101:Suppl. 2 (2004), 14572–14579, 10.1073/pnas.0404838101.
2. Barbalat, R., Ewald, S.E., Mouchess, M.L., Barton, G.M., Nucleic acid recognition by the innate immune system. Annual Review of Immunology 29 (2011), 185–214, 10.1146/annurev-immunol-031210-101340.
3. Baylin, S.B., Jones, P.A., A decade of exploring the cancer epigenome—Biological and translational implications. Nature Reviews. Cancer 11:10 (2011), 726–734, 10.1038/nrc3130.
4. Calin, G.A., Croce, C.M., Microrna signatures in human cancers. Nature Reviews. Cancer 6:11 (2006), 857–866.
5. Cameron, E.E., Bachman, K.E., Myohanen, S., Herman, J.G., Baylin, S.B., Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer. Nature Genetics 21:1 (1999), 103–107, 10.1038/5047.
6. Carmon, K.S., Gong, X., Lin, Q., Thomas, A., Liu, Q., R-spondins function as ligands of the orphan receptors lgr4 and lgr5 to regulate wnt/beta-catenin signaling. Proceedings of the National Academy of Sciences of the United States of America 108:28 (2011), 11452–11457, 10.1073/pnas.1106083108.
7. Chiappinelli, K.B., Strissel, P.L., Desrichard, A., Li, H., Henke, C., Akman, B., et al. Inhibiting DNA methylation causes an interferon response in cancer via dsRNA including endogenous retroviruses. Cell 162:5 (2015), 974–986, 10.1016/j.cell.2015.07.011.
8. Collins, P.L., Kyle, K.E., Egawa, T., Shinkai, Y., Oltz, E.M., The histone methyltransferase setdb1 represses endogenous and exogenous retroviruses in b lymphocytes. Proceedings of the National Academy of Sciences of the United States of America 112:27 (2015), 8367–8372, 10.1073/pnas.1422187112.
9. de Lau, W., Barker, N., Low, T.Y., Koo, B.K., Li, V.S., Teunissen, H., et al. Lgr5 homologues associate with wnt receptors and mediate r-spondin signalling. Nature 476:7360 (2011), 293–297, 10.1038/nature10337.
10. Ding, S., Khoury-Hanold, W., Iwasaki, A., Robek, M.D., Epigenetic reprogramming of the type III interferon response potentiates antiviral activity and suppresses tumor growth. PLoS Biology, 12(1), 2014, e1001758, 10.1371/journal.pbio.1001758.
11. Eden, A., Gaudet, F., Waghmare, A., Jaenisch, R., Chromosomal instability and tumors promoted by DNA hypomethylation. Science, 300(5618), 2003, 455, 10.1126/science.1083557.
12. Gal-Yam, E.N., Saito, Y., Egger, G., Jones, P.A., Cancer epigenetics: Modifications, screening, and therapy. Annual Review of Medicine 59 (2008), 267–280, 10.1146/annurev.med.59.061606.095816.
13. Garzon, R., Calin, G.A., Croce, C.M., Micrornas in cancer. Annual Review of Medicine 60 (2009), 167–179, 10.1146/annurev.med.59.053006.104707.
14. Gotzinger, N., Sauter, M., Roemer, K., Mueller-Lantzsch, N., Regulation of human endogenous retrovirus-k gag expression in teratocarcinoma cell lines and human tumours. The Journal of General Virology 77:Pt. 12 (1996), 2983–2990, 10.1099/0022-1317-77-12-2983.
15. Groudine, M., Eisenman, R., Weintraub, H., Chromatin structure of endogenous retroviral genes and activation by an inhibitor of DNA methylation. Nature 292:5821 (1981), 311–317.
16. Hibino, S., Saito, Y., Muramatsu, T., Otani, A., Kasai, Y., Kimura, M., et al. Inhibitors of enhancer of zeste homolog 2 (ezh2) activate tumor-suppressor microRNAs in human cancer cells. Oncogenesis, 3, 2014, e104, 10.1038/oncsis.2014.17.
17. Hurst, T.P., Magiorkinis, G., Activation of the innate immune response by endogenous retroviruses. The Journal of General Virology 96:Pt. 6 (2015), 1207–1218, 10.1099/jgv.0.000017 0.1099/jgv.0.000017.
18. Jenuwein, T., Allis, C.D., Translating the histone code. Science 293:5532 (2001), 1074–1080, 10.1126/science.1063127.
19. Jones, P.A., Baylin, S.B., The fundamental role of epigenetic events in cancer. Nature Reviews. Genetics 3:6 (2002), 415–428, 10.1038/nrg816.
20. Jones, P.A., Baylin, S.B., The epigenomics of cancer. Cell 128:4 (2007), 683–692, 10.1016/j.cell.2007.01.029.
21. Juergens, R.A., Wrangle, J., Vendetti, F.P., Murphy, S.C., Zhao, M., Coleman, B., et al. Combination epigenetic therapy has efficacy in patients with refractory advanced non-small cell lung cancer. Cancer Discovery 1:7 (2011), 598–607, 10.1158/2159-8290.CD-11-0214.
22. Karpf, A.R., Lasek, A.W., Ririe, T.O., Hanks, A.N., Grossman, D., Jones, D.A., Limited gene activation in tumor and normal epithelial cells treated with the DNA methyltransferase inhibitor 5-aza-2'-deoxycytidine. Molecular Pharmacology 65:1 (2004), 18–27, 10.1124/mol.65.1.18.
23. Karpf, A.R., Peterson, P.W., Rawlins, J.T., Dalley, B.K., Yang, Q., Albertsen, H., et al. Inhibition of DNA methyltransferase stimulates the expression of signal transducer and activator of transcription 1, 2, and 3 genes in colon tumor cells. Proceedings of the National Academy of Sciences of the United States of America 96:24 (1999), 14007–14012.
24. Kelly, T.K., De Carvalho, D.D., Jones, P.A., Epigenetic modifications as therapeutic targets. Nature Biotechnology 28:10 (2010), 1069–1078, 10.1038/nbt.1678.
25. Kondo, Y., Shen, L., Cheng, A.S., Ahmed, S., Boumber, Y., Charo, C., et al. Gene silencing in cancer by histone h3 lysine 27 trimethylation independent of promoter DNA methylation. Nature Genetics 40:6 (2008), 741–750, 10.1038/ng.159.
26. Kouzarides, T., Chromatin modifications and their function. Cell 128:4 (2007), 693–705, 10.1016/j.cell.2007.02.005.
27. Laird, P.W., Jackson-Grusby, L., Fazeli, A., Dickinson, S.L., Jung, W.E., Li, E., et al. Suppression of intestinal neoplasia by DNA hypomethylation. Cell 81:2 (1995), 197–205.
28. Lavie, L., Kitova, M., Maldener, E., Meese, E., Mayer, J., Cpg methylation directly regulates transcriptional activity of the human endogenous retrovirus family herv-k(hml-2). Journal of Virology 79:2 (2005), 876–883, 10.1128/JVI.79.2.876-883.2005.
29. Li, H., Chiappinelli, K.B., Guzzetta, A.A., Easwaran, H., Yen, R.W., Vatapalli, R., et al. Immune regulation by low doses of the DNA methyltransferase inhibitor 5-azacitidine in common human epithelial cancers. Oncotarget 5:3 (2014), 587–598, 10.18632/oncotarget.1782.
30. Liang, G., Lin, J.C., Wei, V., Yoo, C., Cheng, J.C., Nguyen, C.T., et al. Distinct localization of histone h3 acetylation and h3-k4 methylation to the transcription start sites in the human genome. Proceedings of the National Academy of Sciences of the United States of America 101:19 (2004), 7357–7362, 10.1073/pnas.0401866101.
31. Liu, S., Brind'Amour, J., Karimi, M.M., Shirane, K., Bogutz, A., Lefebvre, L., et al. Setdb1 is required for germline development and silencing of h3k9me3-marked endogenous retroviruses in primordial germ cells. Genes & Development 28:18 (2014), 2041–2055, 10.1101/gad.244848.114.
32. Matsui, T., Leung, D., Miyashita, H., Maksakova, I.A., Miyachi, H., Kimura, H., et al. Proviral silencing in embryonic stem cells requires the histone methyltransferase eset. Nature 464:7290 (2010), 927–931, 10.1038/nature08858.
33. Okano, M., Xie, S., Li, E., Cloning and characterization of a family of novel mammalian DNA (cytosine-5) methyltransferases. Nature Genetics 19:3 (1998), 219–220, 10.1038/890.
34. Roulois, D., Loo Yau, H., Singhania, R., Wang, Y., Danesh, A., Shen, S.Y., et al. DNA-demethylating agents target colorectal cancer cells by inducing viral mimicry by endogenous transcripts. Cell 162:5 (2015), 961–973, 10.1016/j.cell.2015.07.056.
35. Saito, Y., Friedman, J.M., Chihara, Y., Egger, G., Chuang, J.C., Liang, G., Epigenetic therapy upregulates the tumor suppressor microrna-126 and its host gene egfl7 in human cancer cells. Biochemical and Biophysical Research Communications 379:3 (2009), 726–731, 10.1016/j.bbrc.2008.12.098.
36. Saito, Y., Liang, G., Egger, G., Friedman, J.M., Chuang, J.C., Coetzee, G.A., et al. Specific activation of microrna-127 with downregulation of the proto-oncogene bcl6 by chromatin-modifying drugs in human cancer cells. Cancer Cell 9:6 (2006), 435–443.
37. Saito, Y., Nakaoka, T., Sakai, K., Muramatsu, T., Toshimitsu, K., Kimura, M., et al. Inhibition of DNA methylation suppresses intestinal tumor organoids by inducing an anti-viral response. Scientific Reports, 6, 2016, 25311, 10.1038/srep25311.
38. Saito, Y., Suzuki, H., Tsugawa, H., Nakagawa, I., Matsuzaki, J., Kanai, Y., et al. Chromatin remodeling at alu repeats by epigenetic treatment activates silenced microrna-512-5p with downregulation of mcl-1 in human gastric cancer cells. Oncogene 28:30 (2009), 2738–2744, 10.1038/onc.2009.140.
39. Sato, T., Vries, R.G., Snippert, H.J., van de Wetering, M., Barker, N., Stange, D.E., et al. Single lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche. Nature 459:7244 (2009), 262–265, 10.1038/nature07935.
40. Stengel, S., Fiebig, U., Kurth, R., Denner, J., Regulation of human endogenous retrovirus-k expression in melanomas by cpg methylation. Genes, Chromosomes & Cancer 49:5 (2010), 401–411, 10.1002/gcc.20751.
41. Strissel, P.L., Ruebner, M., Thiel, F., Wachter, D., Ekici, A.B., Wolf, F., et al. Reactivation of codogenic endogenous retroviral (erv) envelope genes in human endometrial carcinoma and prestages: Emergence of new molecular targets. Oncotarget 3:10 (2012), 1204–1219, 10.18632/oncotarget.679.
42. Suzuki, K., Suzuki, I., Leodolter, A., Alonso, S., Horiuchi, S., Yamashita, K., et al. Global DNA demethylation in gastrointestinal cancer is age dependent and precedes genomic damage. Cancer Cell 9:3 (2006), 199–207, 10.1016/j.ccr.2006.02.016.
43. Tsai, H.C., Li, H., Van Neste, L., Cai, Y., Robert, C., Rassool, F.V., et al. Transient low doses of DNA-demethylating agents exert durable antitumor effects on hematological and epithelial tumor cells. Cancer Cell 21:3 (2012), 430–446, 10.1016/j.ccr.2011.12.029.
44. van de Wetering, M., Francies, H.E., Francis, J.M., Bounova, G., Iorio, F., Pronk, A., et al. Prospective derivation of a living organoid biobank of colorectal cancer patients. Cell 161:4 (2015), 933–945, 10.1016/j.cell.2015.03.053.
45. Wrangle, J., Wang, W., Koch, A., Easwaran, H., Mohammad, H.P., Vendetti, F., et al. Alterations of immune response of non-small cell lung cancer with azacytidine. Oncotarget 4:11 (2013), 2067–2079, 10.18632/oncotarget.1542.
46. Yamashita, M., Toyota, M., Suzuki, H., Nojima, M., Yamamoto, E., Kamimae, S., et al. DNA methylation of interferon regulatory factors in gastric cancer and noncancerous gastric mucosae. Cancer Science 101:7 (2010), 1708–1716, 10.1111/j.1349-7006.2010.01581.x.
47. Yao, J.Y., Zhang, L., Zhang, X., He, Z.Y., Ma, Y., Hui, L.J., et al. H3k27 trimethylation is an early epigenetic event of p16ink4a silencing for regaining tumorigenesis in fusion reprogrammed hepatoma cells. The Journal of Biological Chemistry 285:24 (2010), 18828–18837, 10.1074/jbc.M109.077974.
48. Yoo, C.B., Chuang, J.C., Byun, H.M., Egger, G., Yang, A.S., Dubeau, L., et al. Long-term epigenetic therapy with oral zebularine has minimal side effects and prevents intestinal tumors in mice. Cancer Prevention Research (Philadelphia, Pa.) 1:4 (2008), 233–240, 10.1158/1940-6207.CAPR-07-0008.
49. Yoo, C.B., Jones, P.A., Epigenetic therapy of cancer: Past, present and future. Nature Reviews. Drug Discovery 5:1 (2006), 37–50, 10.1038/nrd1930.
50. Zahnow, C.A., Topper, M., Stone, M., Murray-Stewart, T., Li, H., Baylin, S.B., et al. Inhibitors of DNA methylation, histone deacetylation, and histone demethylation: A perfect combination for cancer therapy. Advances in Cancer Research 130 (2016), 55–111, 10.1016/bs.acr.2016.01.007.
51. Zeng, M., Hu, Z., Shi, X., Li, X., Zhan, X., Li, X.D., et al. Mavs, cgas, and endogenous retroviruses in t-independent b cell responses. Science 346:6216 (2014), 1486–1492, 10.1126/science.346.6216.1486.